Total Payments
$425.77
2024 Payments
$35.69
Companies
9
Transactions
15
Medicare Patients
3,355
Medicare Billing
$306,876
Payment Breakdown by Category
Food & Beverage$362.90 (85.2%)
Other$62.87 (14.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $362.90 | 14 | 85.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62.87 | 1 | 14.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $138.70 | 2 | $0 (2019) |
| PFIZER INC. | $91.99 | 5 | $0 (2023) |
| Indivior Inc. | $62.87 | 1 | $0 (2017) |
| Lilly USA, LLC | $40.13 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.00 | 1 | $0 (2019) |
| Exact Sciences Corporation | $17.86 | 1 | $0 (2024) |
| Novo Nordisk Inc | $17.83 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $16.66 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $13.73 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.69 | 2 | Exact Sciences Corporation ($17.86) |
| 2023 | $95.42 | 5 | PFIZER INC. ($55.29) |
| 2020 | $20.66 | 1 | PFIZER INC. ($20.66) |
| 2019 | $180.74 | 4 | Gilead Sciences, Inc. ($138.70) |
| 2017 | $93.26 | 3 | Indivior Inc. ($62.87) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Oncology | ||||||
| 03/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.83 | General |
| 08/29/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: VACCINES | ||||||
| 07/24/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Diabetes | ||||||
| 06/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes | ||||||
| 03/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/10/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/05/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.00 | General |
| 05/07/2019 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 04/08/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.70 | General |
| 11/16/2017 | GlaxoSmithKline, LLC. | BREO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $62.87 | General |
| Category: OUD | ||||||
| 05/18/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,333 | 1,777 | $158,835 | $48,133 |
| 2022 | 8 | 695 | 1,050 | $544,640 | $96,737 |
| 2021 | 11 | 779 | 1,160 | $547,620 | $101,968 |
| 2020 | 11 | 548 | 837 | $256,705 | $60,037 |
Total Patients
3,355
Total Services
4,824
Medicare Billing
$306,876
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 378 | $86,184 | $30,011 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $5,292 | $2,598 | 49.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 77 | 87 | $12,441 | $2,495 | 20.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 86 | 99 | $8,019 | $1,597 | 19.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 83 | 92 | $6,716 | $1,345 | 20.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 87 | 98 | $4,606 | $1,273 | 27.6% |
| 82746 | Folic acid level, serum | Office | 2023 | 74 | 82 | $5,822 | $1,167 | 20.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 88 | 106 | $4,876 | $1,087 | 22.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 84 | 94 | $4,418 | $885.36 | 20.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 85 | 96 | $2,880 | $830.96 | 28.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 111 | $822.00 | $731.32 | 89.0% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 85 | 99 | $2,871 | $627.66 | 21.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 14 | $1,400 | $556.22 | 39.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 22 | 22 | $770.00 | $384.12 | 49.9% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 71 | 82 | $1,394 | $342.76 | 24.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 16 | 16 | $1,386 | $302.72 | 21.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 51 | 53 | $1,484 | $299.98 | 20.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 21 | 23 | $1,518 | $293.92 | 19.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 50 | 52 | $1,300 | $264.16 | 20.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 23 | $621.00 | $236.28 | 38.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $1,782 | $229.95 | 12.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 11 | 11 | $979.00 | $198.22 | 20.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 53 | 58 | $406.00 | $197.78 | 48.7% |
| 83540 | Iron level | Office | 2023 | 21 | 23 | $713.00 | $142.42 | 20.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 15 | $135.00 | $37.62 | 27.9% |
About Dr. Christopher Koke, DO
Dr. Christopher Koke, DO is a Neuromusculoskeletal Medicine & OMM healthcare provider based in Amagansett, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1386958080.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Koke, DO has received a total of $425.77 in payments from pharmaceutical and medical device companies, with $35.69 received in 2024. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($362.90).
As a Medicare-enrolled provider, Koke has provided services to 3,355 Medicare beneficiaries, totaling 4,824 services with total Medicare billing of $306,876. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Other Specialties Family Medicine
- Location Amagansett, NY
- Active Since 08/05/2010
- Last Updated 06/12/2024
- Taxonomy Code 204D00000X
- Entity Type Individual
- NPI Number 1386958080
Products in Payments
- Truvada (Drug) $125.00
- SUBOXONE SUBLINGUAL FILM (Drug) $62.87
- CHANTIX (Drug) $36.70
- ELIQUIS (Drug) $36.19
- TRULICITY (Drug) $22.26
- PREVNAR 20 (Biological) $19.10
- MOUNJARO (Drug) $17.87
- Cologuard Collection Kit (Device) $17.86
- BREO (Drug) $16.66
- BEVESPI AEROSPHERE (Drug) $13.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.